Epsilon M&A Deal Report - Pharmaceutical Devices and Prescription Retail Packaging divisions of Rexam
Transaction Multiples for the Valuation of Private Companies
Private Group led by Montagu Private Equity > Pharmaceutical Devices and Prescription Retail Packaging divisions of Rexam
Announced Date : 03 February 2014
Type : MBO (Management Buy Out)
Deal Value : Yes
Acquirer : Private Group led by Montagu Private Equity
Target: Pharmaceutical Devices and Prescription Retail Packaging divisions of Rexam
Target Country: France
Sector of activity : Industrial Goods
Business Description :
> Healthcare Devices (La Verpillière) ...
Transaction multiples available
| EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
|---|---|---|---|---|---|---|---|
| Historic | |||||||
| Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating *
Source: Epsilon Research / EMAT
Comparable Transactions
Number of EMAT Reports : (Industrial Goods) = 875
Example of comparable transactions on EMAT (same sub-sector):
| Date | Acquirer | Target | Country | Multiples | See details |
|---|---|---|---|---|---|
| 16/12/2013 | RPC Group (Rigid Plastic Packaging) | Maynard & Harris Group | United Kingdom | 0 | |
| 21/12/2012 | Private Group Led By Siparex and Somfy Participations | Sofilab (La Buvette) | France | 0 |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database
